Perillyl alcohol inhibits breast cell migration without affecting cell adhesion

Journal of Biomedicine and Biotechnology

Volumn 2002, Issue 3, 2002, Pages 136-140

  Wagner, Johanna E ^a   Huff, Janice L ^a   Rust, William L ^a   Kingsley, Karl ^a   Plopper, George E ^b  

^a UNIVERSITY OF NEVADA   (United States)

^b RENSSELAER POLYTECHNIC INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRONECTIN; LIMONENE; PERILLYL ALCOHOL;

ARTICLE; BREAST CANCER; BREAST CELL; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CELL ADHESION; CELL GROWTH; CELL MIGRATION; CONTROLLED STUDY; CYTOTOXICITY; DRUG INHIBITION; HUMAN; HUMAN CELL; MINIMUM INHIBITORY CONCENTRATION;

EID: 33746966651     PISSN: 11107243     EISSN: 11107251     Source Type: Journal    
DOI: 10.1155/S1110724302207020     Document Type: Article

References (18)

1. Alison M, Sarraf C. Understanding Cancer. London: Cambridge University Press; 1997.
2. Liotta LA. Tumor invasion and metastases-role of the extracellular matrix: Rhoads memorial award lecture. Cancer Res. 1986;46(1):1-7.
3. Kohn EC, Liotta LA. Molecular insights into cancer invasion: strategies for prevention and intervention. Cancer Res. 1995;55(9):1856-1862.
4. Rust WL, Huff JL, Plopper GE. Screening assay for promigratory/ antimigratory compounds. Anal Biochem. 2000;280(1):11-19.
5. Crowell PL, Gould MN. Chemoprevention and therapy of cancer by d-limonene. Crit Rev Oncog. 1994;5(1):122.
6. Crowell PL. Prevention and therapy of cancer by dietary monoterpenes. J Nutr. 1999;129(3):775S-778S.
7. Vigushin DM, Poon GK, Boddy A, et al. Phase I and pharmacokinetic study of d-limonene in patients with advanced cancer. Cancer Chemother Pharmacol. 1998;42(2):111-117.
8. Phillips LR, Malspeis L, Supko JG. Pharmacokinetics of active drug metabolites after oral administration of perillyl alcohol, an investigational antineoplastic agent, to the dog. Drug Metab Dispos. 1995;23(7):676-680.
9. Ren Z, Elson CE, Gould MN. Inhibition of type I and type II geranylgeranyl-protein transferases by the monoterpene perillyl alcohol in NIH3T3 cells. Biochem Pharmacol. 1997;54(1):113-120.
10. Clark SS, Perman SM, Sahin MB, Jenkins GJ, Elegbede JA. Antileukemia activity of perillyl alcohol (POH): uncoupling apoptosis from G0/G1 arrest suggests that the primary effect of POH on Bcr/Abl-transformed cells is to induce growth arrest. Leukemia. 2002;16(2):213-222.
11. Plopper GE, Domanico SZ, Cirulli V, Kiosses WB, Quaranta V. Migration of breast epithelial cells on Laminin-5: differential role of integrins in normal and transformed cell types. Breast Cancer Res Treat. 1998;51(1):57-69.
12. Gelb MH, Tamanoi F, Yokoyama K, Ghomashchi F, Esson K, Gould MN. The inhibition of protein prenyltransferases by oxygenated metabolites of limonene and perillyl alcohol. Cancer Lett. 1995;91(2):169-175.
13. Crowell PL, Ren Z, Lin S, Vedejs E, Gould MN. Structure-activity relationships among monoterpene inhibitors of protein isoprenylation and cell proliferation. Biochem Pharmacol. 1994;47(8):1405-1415.
14. Kjoller L, Hall A. Signaling to Rho GTPases. Exp Cell Res. 1999;253(1):166-179.
15. Yoshioka K, Nakamori S, Itoh K. Overexpression of small GTP-binding protein RhoA promotes invasion of tumor cells. Cancer Res. 1999;59(8):2004-2010.
16. Bourguignon LY, Zhu H, Shao L, Zhu D, Chen YW. Rho-kinase (ROK) promotes CD44v(3,8-10)-ankyrin interaction and tumor cell migration in metastatic breast cancer cells. Cell Motil Cytoskeleton. 1999;43(4):269-287.
17. Stayrook KR, McKinzie JH, Burke YD, Burke YA, Crowell PL. Induction of the apoptosis-promoting protein Bak by perillyl alcohol in pancreatic ductal adenocarcinoma relative to untransformed ductal epithelial cells. Carcinogenesis. 1997;18(8):1655-1658.
18. Duffy SW, Nixon RM. Estimates of the likely prophylactic effect of tamoxifen in women with high risk BRCA1 and BRCA2 mutations. Br J Cancer. 2002;86(2):218-221.